Fresenius SE Operating Margin 2016-2023 | FSNUY

Current and historical operating margin for Fresenius SE (FSNUY) over the last 10 years. The current operating profit margin for Fresenius SE as of September 30, 2023 is 0.00%.
Fresenius SE Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2023-09-30 $39.20B $2.51B 6.40%
2023-06-30 $43.73B $3.02B 6.92%
2023-03-31 $43.10B $3.33B 7.73%
2022-12-31 $43.03B $3.50B 8.13%
2022-09-30 $43.53B $4.09B 9.40%
2022-06-30 $43.99B $4.39B 9.98%
2022-03-31 $44.47B $4.72B 10.61%
2021-12-31 $44.39B $4.92B 11.08%
2021-09-30 $44.08B $4.86B 11.03%
2021-06-30 $43.51B $4.97B 11.43%
2021-03-31 $42.19B $4.98B 11.81%
2020-12-31 $41.44B $5.01B 12.09%
2020-09-30 $40.66B $5.19B 12.76%
2020-06-30 $40.06B $5.14B 12.83%
2020-03-31 $40.09B $5.16B 12.87%
2019-12-31 $39.66B $5.19B 13.08%
2019-09-30 $39.42B $5.18B 13.13%
2019-06-30 $39.12B $5.13B 13.12%
2019-03-31 $39.27B $6.19B 15.77%
2018-12-31 $39.60B $6.20B 15.66%
2018-09-30 $39.76B $6.10B 15.34%
2018-06-30 $39.98B $6.20B 15.50%
2018-03-31 $39.37B $5.16B 13.12%
2017-12-31 $38.30B $5.19B 13.54%
2017-09-30 $36.47B $5.24B 14.35%
2017-06-30 $34.84B $5.12B 14.70%
2017-03-31 $33.47B $5.03B 15.02%
2016-12-31 $32.18B $4.79B 14.88%
2016-09-30 $31.71B $11.39B 35.93%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $18.408B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00